-
1
-
-
38349102172
-
Multifaceted therapeutic benefits of Ginkgo biloba L: Chemistry, efficacy, safety, and uses
-
Mahadevan S, Park Y. Multifaceted therapeutic benefits of Ginkgo biloba L: chemistry, efficacy, safety, and uses. J Food Sci 2008; 73:14-9.
-
(2008)
J Food Sci
, vol.73
, pp. 14-19
-
-
Mahadevan, S.1
Park, Y.2
-
2
-
-
0036343060
-
The CNS effects of Ginkgo biloba extracts and ginkgolide B
-
DOI 10.1016/S0301-0082(02)00015-1, PII S0301008202000151
-
Maclennan KM, Darlington CL, Smith PF. The CNS effects of Ginkgo biloba extracts and ginkgolide B. Prog Neurobiol 2002; 67:235-57. (Pubitemid 34880132)
-
(2002)
Progress in Neurobiology
, vol.67
, Issue.3
, pp. 235-257
-
-
Maclennan, K.M.1
Darlington, C.L.2
Smith, P.F.3
-
3
-
-
12344295476
-
Clinical use and molecular mechanisms of action of extract of Ginkgo biloba leaves in cardiovascular diseases
-
Zhou W, Chai H, Lin PH, Lumsden AB, Yao Q, Chen C. Clinical use and molecular mechanisms of action of extract of Ginkgo biloba leaves in cardiovascular diseases. Cardiovasc Drug Rev 2004; 22:309-19. (Pubitemid 40123300)
-
(2004)
Cardiovascular Drug Reviews
, vol.22
, Issue.4
, pp. 309-319
-
-
Zhou, W.1
Chai, H.2
Lin, P.H.3
Lumsden, A.B.4
Yao, Q.5
Chen, C.6
-
4
-
-
0042169046
-
Ginkgo biloba extracts and cancer: A research area in its infancy
-
DOI 10.1046/j.1472-8206.2003.00156.x
-
DeFeudis FV, Papadopoulos V, Drieu K. Ginkgo biloba extracts and cancer: a research area in its infancy. Fundam Clin Pharmacol 2003; 17:405-17. (Pubitemid 36920641)
-
(2003)
Fundamental and Clinical Pharmacology
, vol.17
, Issue.4
, pp. 405-417
-
-
DeFeudis, F.V.1
Papadopoulos, V.2
Drieu, K.3
-
5
-
-
0023212249
-
The ginkgolides: Potent platelet-activating factor antagonists isolated from Ginkgo biloba L.: chemistry, pharmacology, and clinical applications
-
Braquet, P. The ginkgolides: potent platelet-activating factor antagonists isolated from Ginkgo biloba L: chemistry, pharmacology and clinical applications. Drugs Future 1987; 12:643-99. (Pubitemid 17110888)
-
(1987)
Drugs of the Future
, vol.12
, Issue.7
, pp. 643-699
-
-
Braquet, P.1
-
6
-
-
0018691869
-
Platelet-activating factor. Evidence for 1-0-alkyl-2-acetyl-sn-glyceryl- 3-phosphorylcholine as the active component (a new class of lipid chemical mediators)
-
Demopoulos CA, Pinckard RN, Hanahan DJ. Platelet-activating factor, evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators). J Biologic Chem 1979; 254:9355-58. (Pubitemid 10248704)
-
(1979)
Journal of Biological Chemistry
, vol.254
, Issue.19
, pp. 9355-9358
-
-
Demopoulos, C.A.1
Pinckard, R.N.2
Hanahan, D.J.3
-
8
-
-
70349540689
-
The implication of platelet activating factor in cancer growth and metastasis: Potent beneficial role of PAF-inhibitors and antioxidants
-
Tsoupras AB, Iatrou C, Frangia C, Demopoulos CA. The implication of platelet activating factor in cancer growth and metastasis: potent beneficial role of PAF-inhibitors and antioxidants. Infect Disord Drug Targets 2009; 9:390-9.
-
(2009)
Infect Disord Drug Targets
, vol.9
, pp. 390-399
-
-
Tsoupras, A.B.1
Iatrou, C.2
Frangia, C.3
Demopoulos, C.A.4
-
9
-
-
33847043565
-
HIV-1 Tat reduces nephrin in human podocytes: A potential mechanism for enhanced glomerular permeability in HIV-associated nephropathy
-
Doublier S, Zennaro C, Spatola T, Lupia E, Bottelli A, Deregibus MC, Carraro M, Conaldi PG, Camussi G. HIV-1 Tat reduces nephrin in human podocytes: a potential mechanism for enhanced glomerular permeability in HIV-associated nephropathy. AIDS 2007; 21:423-32.
-
(2007)
AIDS
, vol.21
, pp. 423-432
-
-
Doublier, S.1
Zennaro, C.2
Spatola, T.3
Lupia, E.4
Bottelli, A.5
Deregibus, M.C.6
Carraro, M.7
Conaldi, P.G.8
Camussi, G.9
-
10
-
-
14444276732
-
Platelet-activating factor receptor activation. An initiator step in HIV-1 neuropathogenesis
-
DOI 10.1074/jbc.273.28.17660
-
Perry SW, Hamilton JA, Tjoelker LW, et al. Platelet-activating factor receptor activation. An initiator step in HIV-1 neuropathogenesis. J Biol Chem 1998; 273:17660-64. (Pubitemid 28355104)
-
(1998)
Journal of Biological Chemistry
, vol.273
, Issue.28
, pp. 17660-17664
-
-
Perry, S.W.1
Hamilton, J.A.2
Tjoelker, L.W.3
Dbaibo, G.4
Dzenko, K.A.5
Epstein, L.G.6
Hannun, Y.7
Steven, W.J.8
Dewhurst, S.9
Gelbard, H.A.10
-
11
-
-
0032732223
-
Motility induced by human immunodeficiency virus-1 Tat on Kaposi's sarcoma cells requires platelet-activating factor synthesis
-
Biancone L, Cantaluppi V, Boccellino M, Bussolati B, Del Sorbo L, Conaldi PG, Albini A, Toniolo A, Camussi G. Motility induced by human immunodeficiency virus-1 Tat on Kaposi's sarcoma cells requires platelet-activating factor synthesis. Am J Pathol 1999; 155:1731-39.
-
(1999)
Am J Pathol
, vol.155
, pp. 1731-1739
-
-
Biancone, L.1
Cantaluppi, V.2
Boccellino, M.3
Bussolati, B.4
Del Sorbo, L.5
Conaldi, P.G.6
Albini, A.7
Toniolo, A.8
Camussi, G.9
-
12
-
-
0033734832
-
PMS-601, a new platelet-activating factor receptor antagonist that inhibits human immunodeficiency virus replication and potentiates zidovudine activity in macrophages
-
Martin M, Serradji N, Dereuddre-Bosquet N, et al. PMS-601, a new platelet-activating factor receptor antagonist that inhibits human immunodeficiency virus replication and potentiates zidovudine activity in macrophages. Antimicrob Agents Chemother 2000; 44:3150-54.
-
(2000)
Antimicrob Agents Chemother
, vol.44
, pp. 3150-3154
-
-
Martin, M.1
Serradji, N.2
Dereuddre-Bosquet, N.3
-
13
-
-
50249161540
-
Anti-platelet-activating factor effects of highly active antiretroviral therapy (HAART): A new insight in the drug therapy of HIV infection?
-
Tsoupras AB, Chini M, Tsogas N, et al. Anti-platelet-activating factor effects of highly active antiretroviral therapy (HAART): a new insight in the drug therapy of HIV infection? AIDS Res Hum Retroviruses 2008; 24:1079-86.
-
(2008)
AIDS Res Hum Retroviruses
, vol.24
, pp. 1079-1086
-
-
Tsoupras, A.B.1
Chini, M.2
Tsogas, N.3
-
14
-
-
0344081893
-
Platelet-Activating Factor, a Pleiotrophic Mediator of Physiological and Pathological Processes
-
Stafforini DM, McIntyre TM, Zimmerman GA, Prescott SM. Platelet-activating factor, a pleiotrophic mediator of physiological and pathological processes. Crit Rev Cl Lab Sci 2003; 40:643-72. (Pubitemid 37491708)
-
(2003)
Critical Reviews in Clinical Laboratory Sciences
, vol.40
, Issue.6
, pp. 643-672
-
-
Stafforini, D.M.1
McIntyre, T.M.2
Zimmerman, G.A.3
Prescott, S.M.4
-
15
-
-
0028982689
-
Platelet-activating factor and its analogs: Metabolic pathways and related intracellular processes
-
Snyder F. Platelet-activating factor and its analogs: metabolic pathways and related intracellular processes. Biochim Biophys Acta 1995; 1254:231-49.
-
(1995)
Biochim Biophys Acta
, vol.1254
, pp. 231-249
-
-
Snyder, F.1
-
16
-
-
0033932891
-
Properties and regulation of microsomal PAF-synthesizing enzymes in rat brain cortex
-
DOI 10.1023/A:1007523422825
-
Francescangeli E, Boila A, Goracci G. Properties and regulation of microsomal PAF-synthesizing enzymes in rat brain cortex. Neurochem Res 2000; 25:705-13. (Pubitemid 30422005)
-
(2000)
Neurochemical Research
, vol.25
, Issue.5
, pp. 705-713
-
-
Francescangeli, E.1
Boila, A.2
Goracci, G.3
-
17
-
-
0031552933
-
CDP-choline: Alkylacetylglycerol cholinephosphotransferase catalyzes the final step in the de novo synthesis of platelet-activating factor
-
DOI 10.1016/S0005-2760(97)00109-4, PII S0005276097001094
-
Snyder F. CDP-choline: alkylacetylglycerol choline phosphotransferase catalyzes the final step in the de novo synthesis of platelet-activating factor. Biochim Biophys Acta 1997; 1348:111-6. (Pubitemid 27467083)
-
(1997)
Biochimica et Biophysica Acta - Lipids and Lipid Metabolism
, vol.1348
, Issue.1-2
, pp. 111-116
-
-
Snyder, F.1
-
18
-
-
0023278621
-
Human plasma platelet-activating factor acetylhydrolase. Association with lipoprotein particles and role in the degradation of platelet-activating factor
-
Stafforini DM, McIntyre TM, Carter ME, Prescott SM. Human plasma platelet-activating factor acetylhydrolase. Association with lipoprotein particles and role in the degradation of platelet-activating factor. J Biol Chem 1987; 262:4215-22. (Pubitemid 17102639)
-
(1987)
Journal of Biological Chemistry
, vol.262
, Issue.9
, pp. 4215-4222
-
-
Stafforini, D.M.1
McIntyre, T.M.2
Carter, M.E.3
Prescott, S.M.4
-
19
-
-
0025617943
-
Platelet-activating factor activates HIV promoter in transfected SH-SY5Y neuroblastoma cells and MOLT-4 T lymphocytes
-
Squinto SP, Braquet P, Block AL, Bazan NG. Platelet-activating factor activates HIV promoter in transfected SH-SY5Y neuroblastoma cells and MOLT-4 T lymphocytes. J Mol Neurosci 1990; 2:79-84.
-
(1990)
J Mol Neurosci
, vol.2
, pp. 79-84
-
-
Squinto, S.P.1
Braquet, P.2
Block, A.L.3
Bazan, N.G.4
-
20
-
-
33748745311
-
2, PAF, and vitronectin receptor
-
DOI 10.1089/aid.2006.22.763
-
Lima RG, Moreira L, Paes-Leme J, Barreto-de-Souza V, Castro-Faria-Neto HC, Bozza PT, Bou-Habib DC. Interaction of macrophages with apoptotic cells enhances HIV Type 1 replication through PGE2, PAF, and vitronectin receptor. AIDS Res Hum Retroviruses 2006; 22:763-9. (Pubitemid 44735003)
-
(2006)
AIDS Research and Human Retroviruses
, vol.22
, Issue.8
, pp. 763-769
-
-
Lima, R.G.1
Moreira, L.2
Paes-Leme, J.3
Barreto-De-Souza, V.4
Castro-Faria-Neto, H.C.5
Bozza, P.T.6
Bou-Habib, D.C.7
-
21
-
-
47149099553
-
Characterization of the de novo biosynthetic enzyme of platelet activating factor, DDT-insensitive cholinephosph otransferase, of human mesangial cells
-
Tsoupras AB, Fragopoulou E, Nomikos T, Iatrou C, Antonopoulou S, Demopoulos CA. Characterization of the de novo biosynthetic enzyme of platelet activating factor, DDT-insensitive cholinephosph otransferase, of human mesangial cells. Mediators Inflamm 2007; 2007:27683.
-
(2007)
Mediators Inflamm
, vol.2007
, pp. 27683
-
-
Tsoupras, A.B.1
Fragopoulou, E.2
Nomikos, T.3
Iatrou, C.4
Antonopoulou, S.5
Demopoulos, C.A.6
-
22
-
-
79951654828
-
In vitro and in vivo effects of statins on platelet activating factor and its metabolism
-
Epub ahead of print
-
Tsantila N, Tsoupras AB, Fragopoulou E, Antonopoulou S, Iatrou C, Demopoulos CA. In vitro and in vivo effects of statins on platelet activating factor and its metabolism. Angiology 2010; Epub ahead of print.
-
(2010)
Angiology
-
-
Tsantila, N.1
Tsoupras, A.B.2
Fragopoulou, E.3
Antonopoulou, S.4
Iatrou, C.5
Demopoulos, C.A.6
-
23
-
-
0017184389
-
A rapid and sensitive method for the quantization of microgram quantities of protein utilizing the principle of protein-dye binding
-
Bradford MM. A rapid and sensitive method for the quantization of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72:248-54.
-
(1976)
Anal Biochem
, vol.72
, pp. 248-254
-
-
Bradford, M.M.1
-
24
-
-
33845261493
-
A rapid method of total lipid extraction and purification
-
Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959; 37:911-7.
-
(1959)
Can J Biochem Physiol
, vol.37
, pp. 911-917
-
-
Bligh, E.G.1
Dyer, W.J.2
-
25
-
-
0028168481
-
Platelet-activating factor acetylhydrolase (PAF-AH) in human kidney
-
Antonopoulou S, Demopoulos CA, Iatrou C, Moustakas G, Zirogiannis P. Platelet-activating factor acetylhydrolase (PAF-AH) in human kidney. Int J Biochem 1994; 26:1157-62.
-
(1994)
Int J Biochem
, vol.26
, pp. 1157-1162
-
-
Antonopoulou, S.1
Demopoulos, C.A.2
Iatrou, C.3
Moustakas, G.4
Zirogiannis, P.5
-
26
-
-
85038485839
-
Platelet Activating Factor (PAF)-Metabolism in Blood of HIV Infected, Naïve Patients and Healthy Controls
-
Chini M, Tsoupras AB, Mangafas N, et al. Platelet Activating Factor (PAF)-Metabolism in Blood of HIV Infected, Naïve Patients and Healthy Controls. 48th IDSA Annual Meeting, Vancouver 2010; 1087.
-
48th IDSA Annual Meeting, Vancouver 2010
, pp. 1087
-
-
Chini, M.1
Tsoupras, A.B.2
Mangafas, N.3
-
27
-
-
38349057863
-
Protection against human immunodeficiency virus type 1 Tat neurotoxicity by Ginkgo biloba extract EGb 761 involving glial fibrillary acidic protein
-
Zou W, Kim BO, Zhou BY, Liu Y, Messing A, He JJ. Protection against human immunodeficiency virus type 1 Tat neurotoxicity by Ginkgo biloba extract EGb 761 involving glial fibrillary acidic protein. Am J Pathol 2007; 171:1923-35.
-
(2007)
Am J Pathol
, vol.171
, pp. 1923-1935
-
-
Zou, W.1
Kim, B.O.2
Zhou, B.Y.3
Liu, Y.4
Messing, A.5
He, J.J.6
-
28
-
-
50649097050
-
Inhibition of HIV-1 protease and RNase H of HIV-1 reverse transcriptase activities by long chain phenols from the sarcotestas of Ginkgo biloba
-
Lee JS, Hattori M, Kim J. Inhibition of HIV-1 protease and RNase H of HIV-1 reverse transcriptase activities by long chain phenols from the sarcotestas of Ginkgo biloba. Planta Med 2008; 74:1320.
-
(2008)
Planta Med
, vol.74
, pp. 1320
-
-
Lee, J.S.1
Hattori, M.2
Kim, J.3
-
29
-
-
81855183044
-
Effects of Highly Active Antiretroviral Therapy (HAART) on Platelet Activating Factor (PAF) metabolism in HIV-infected patients: In vivo results
-
Tsoupras AB, Chini M, Tsogas N, Mangafas N, Stamatakis G, Antonopoulou S, Demopoulos CA, Lazanas MC. Effects of Highly Active Antiretroviral Therapy (HAART) on Platelet Activating Factor (PAF) metabolism in HIV-infected patients: in vivo results. J Int AIDS Soc 2008; 11:1758-2652.
-
(2008)
J Int AIDS Soc
, vol.11
, pp. 1758-2652
-
-
Tsoupras, A.B.1
Chini, M.2
Tsogas, N.3
Mangafas, N.4
Stamatakis, G.5
Antonopoulou, S.6
Demopoulos, C.A.7
Lazanas, M.C.8
-
30
-
-
0032739886
-
Plasma platelet-activating factor acetylhydrolase activity in human immunodeficiency virus infection and the acquired immunodeficiency syndrome
-
Khovidhunkit W, Memon RA, Shigenaga JK, Pang M, Schambelan M, Mulligan K, Feingold KR, Grunfeld C. Plasma platelet-activating factor acetylhydrolase activity in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Metabolism 1999; 48:1524-31.
-
(1999)
Metabolism
, vol.48
, pp. 1524-1531
-
-
Khovidhunkit, W.1
Memon, R.A.2
Shigenaga, J.K.3
Pang, M.4
Schambelan, M.5
Mulligan, K.6
Feingold, K.R.7
Grunfeld, C.8
|